Using their proprietary platform technology, GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin's lymphoma, acute myeloid leukemia and multiple solid tumors.
© Copyright 1997-2024 VoiceAmerica Internet Talk Radio.The World Leader in Internet Talk Radio. All Rights Reserved.
